NASDAQ:SILK • US82710M1009
Past quarterly earnings results for SILK ROAD MEDICAL INC (SILK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | -0.42 | -0.38 | -9.60% | -20.00% | 51.242M | 50.596M | 1.28% | 13.12% |
| Q1 2024 | -0.36 | -0.41 | 12.31% | 16.28% | 48.484M | 45.569M | 6.40% | 20.81% |
| Q4 2023 | -0.33 | -0.43 | 23.20% | 2.94% | 47.27M | 42.813M | 10.41% | 17.97% |
| Q3 2023 | -0.33 | -0.36 | 8.23% | -13.79% | 44.435M | 45.435M | -2.20% | 18.91% |
| Q2 2023 | -0.35 | -0.40 | 11.99% | 18.60% | 45.298M | 44.103M | 2.71% | 36.56% |
| Q1 2023 | -0.43 | -0.40 | -7.15% | 10.42% | 40.131M | 41.504M | -3.31% | 43.22% |
| Q4 2022 | -0.34 | -0.38 | 11.58% | 19.05% | 40.07M | 38.094M | 5.19% | 41.74% |
| Q3 2022 | -0.29 | -0.43 | 33.17% | 27.50% | 37.37M | 34.308M | 8.93% | 51.30% |
| Q2 2022 | -0.43 | -0.47 | 8.39% | -38.71% | 33.17M | 31.647M | 4.81% | 25.36% |
| Q1 2022 | -0.48 | -0.38 | -26.61% | -54.84% | 28.02M | 27.64M | 1.37% | 27.07% |
| Q4 2021 | -0.42 | -0.36 | -15.34% | 14.29% | 28.27M | 26.418M | 7.01% | 33.79% |
| Q3 2021 | -0.40 | -0.31 | -30.28% | -29.03% | 24.7M | 26.756M | -7.68% | 23.07% |
| Q2 2021 | -0.31 | -0.37 | 16.81% | 3.13% | 26.46M | 25.839M | 2.40% | 75.35% |
| Q1 2021 | -0.31 | -0.40 | 22.27% | 3.13% | 22.05M | 21.722M | 1.51% | 16.48% |
| Q4 2020 | -0.49 | -0.29 | -71.88% | - | 21.13M | 21.768M | -2.93% | - |
| Q3 2020 | -0.31 | -0.29 | -6.58% | - | 20.07M | 19.983M | 0.44% | - |
| Q2 2020 | -0.32 | -0.38 | 14.89% | - | 15.09M | 9.652M | 56.34% | - |
| Q1 2020 | -0.32 | -0.32 | -1.20% | - | 18.93M | 17.673M | 7.11% | - |
Notes
SILK ROAD MEDICAL INC (SILK) last reported earnings on 8/7/2024.
SILK ROAD MEDICAL INC (SILK) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, SILK ROAD MEDICAL INC (SILK) has beaten EPS estimates in 3 out of 4 releases.